| EPA0007 | Identification of a new HIV-1 BF1 intersubtype recombinant form circulating in Turkey, that has generated a secondary recombinant form with CRF56_cpx transmitted in Spain | E-poster | HIV virology |
| EPA0053 | Identification of novel PTPN1/PTPN2 inhibitors to target latent HIV reservoirs | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0028 | Identification of SIV infected mast cells in early sites of viral rebound | E-poster | HIV pathogenesis |
| EPE0952 | Identification of strategies to enhance the provision of holistic services across three community-based organizations in Seattle | E-poster | Integration of HIV services with other health and support services |
| EPE0983 | Identifying efficiency estimates and associated factors for HIV testing, treatment, and viral load suppression programs in 25 PEPFAR-supported countries, 2016-2021 | E-poster | Innovations in data collection, monitoring and evaluation |
| EPC0502 | Identifying gaps in the HIV care continuum among indigenous Mayan persons living with HIV in Guatemala | E-poster | Cascades of HIV care and treatment |
| OAD0503 | Identifying longitudinal patterns of HIV treatment (dis)engagement and re-engagement from oral histories of virologically unsuppressed adults in Uganda: a thematic trajectory analysis | Oral abstract session with live Q&A | Social and behavioural aspects and approaches to HIV |
| EPD0633 | Identifying syndemic determinants of condom use among Nigerian youth: a latent class analysis | E-poster | Social, political, legal and behavioural determinants of health in different contexts |
| EPD0568 | Identifying the differentiating characteristics of HIV treatment clients with advanced HIV disease in Kyrgyzstan | E-poster | Social and behavioural aspects and approaches to HIV |
| EPE1006 | Identifying the drivers and influencers of COVID-19 vaccine hesitancy in Nigeria | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |